Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based StudyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|American Journal of Respiratory and Critical Care Medicine|2023Cited by 79
EXACOS CARBON: Describing the Greenhouse Gas Emissions of Healthcare Resource Utilization by Frequency and Severity of COPD Exacerbation in EnglandJohn Bell, Jennifer K Quint, Emily L. Graul et al.|Unknown|2024Cited by 5
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated CardiomyopathyUpasana Tayal, Jennifer K Quint, Georgie M Massen et al.|JAMA Cardiology|2025Cited by 5
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|BMC Pulmonary Medicine|2024Cited by 3
The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populationsAnne E Ioannides, Jennifer K. Quint, Emily L. Graul et al.|BMC Medicine|2026Cited by 1